1 |
Fu, Y., N. Luo, and M. F. Lopes-Virella. 2002. Upregulation of interleukin-8 expression by prostaglandin in human THP-1 macrophages. Atherosclerosis 160: 11-20
DOI
ScienceOn
|
2 |
Kelly, G., B. Robert, R. Chris, G. Gary, H. Perry, and C. James. 2001. Differential effects of 15-deoxy--prostaglandin and a peroxisome proliferator-activated receptor agonist on macrophage activation. J. Leukoc. Biol. 69: 631-638
|
3 |
Kim, J. E., H. J. Hur, K. W. Lee, and H. J. Lee. 2007. Antiinflammatory effects of recombinant arginine deiminase originating from Lactococcus lactis ssp. lactis ATCC 7962. J. Microbiol. Biotechnol. 17: 1491-1497
과학기술학회마을
|
4 |
Marx, N., F. Mach, A. Sauty, J. H. Leung, M. N. Sarafi, R. M. Randohoff, P. Libby, J. Plutzky, and A. D. Luster. 2000. Peroxisome proliferator-activated receptor- activators inhibit IFN--induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164: 6503-6508
DOI
|
5 |
Rossi, A., G. Elia, and M. G. Santoro. 1997. Inhibition of nuclear factor B by prostaglandin A1: An effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA 94: 746-750
|
6 |
Wilmer, W. A., C. Dixon, L. Lu, T. Hilbelink, and B. H. Rovin. 2001. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPAR . Biochem. Biophys. Res.Commun. 281: 57-62
DOI
ScienceOn
|
7 |
Zhang, X., J. M. Wang, W. H. Gong, N. Mukaida, and H. A. Young. 2001. Differential regulation of chemokine gene expression by 15-deoxy--prostaglandin . J. Immunol. 166: 7104-7111
DOI
|
8 |
Ricote, M., J. T. Huang, J. S. Welch, and C. K. Glass. 1999. The peroxisome proliferator-activated receptor (PPAR) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66: 733-739
DOI
|
9 |
Masamune, A., K. Kikuta, M. Satoh, Y. Sakai, A. Satoh, and T. Shimosegawa. 2002. Ligands of peroxisome proliferator activated receptor- block activation of pancreatic stellate cells. J. Biol. Chem. 277: 141-147
DOI
ScienceOn
|
10 |
Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor- is a negative regulator of macrophage activation. Nature 391: 79- 82
DOI
ScienceOn
|
11 |
Sawano, H., M. Haneda, T. Sugimoto, K. Inoki, D. Koya, and R. Kikkawa. 2002. 15-Deoxy--prostaglandin inhibits IL- 1-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int. 61: 1957-1967
DOI
ScienceOn
|
12 |
Erl, W., C. Weber, A. Zernecke, J. Neuzil, C. A. Vosseler, H. J. Kim, and P. C. Weber. 2004. Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-. Eur. J. Immunol. 34: 241-250
DOI
ScienceOn
|
13 |
Chinetti, G., J. C. Fruchart, and B. Staels. 2000. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49: 497-505
DOI
ScienceOn
|
14 |
Reilly, C. M., J. C. Oates, J. Suidan, M. B. Crosby, P. V. Halushka, and G. S. Gilkeson. 2001. Prostaglandin inhibition of mesangial cell iNOS expression. Clin. Immunol. 3: 337-345
|
15 |
Clark, R. B. 2002. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71: 388-400
|
16 |
Meade, E. A., T. M. Mcintyre, G. A. Zimmerman, and S. M. Prescott. 1999. Peroxisome proliferators enhance cyclooxygenase- 2 expression in epithelial cells. J. Biol. Chem. 274: 8328-8334
DOI
ScienceOn
|
17 |
Cunard, R., M. Ricote, D. DiCampli, D. C. Archer, D. A. Kahn, C. K. Glass, C. J. Kelly, and M. Ricote. 2002. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J. Immunol. 168: 2795-2802
DOI
|
18 |
Harris, S. G., R. S. Smith, and R. P. Phipps. 2002. 15-Deoxy- induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168: 1372-1379
DOI
|
19 |
Bureau, F., C. Desmet, D. Melotte, F. Jaspar, C. Volanti, A. Vanderplasschen, P. P. Pastoret, J. Piette, and P. Lekeux. 2002. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: Oxidative stress-induced extracellular signal-regulated kinase activation without NFkappa B inhibition. J. Immunol. 168: 5318-5325
DOI
|
20 |
Kim, H. Y. and H. S. Kim. 2007. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy--prostaglandin in mouse peritoneal macrophages. Immunol. Cell Biol. 85: 60-67
|
21 |
Jostarndt, K., T. Rubic, H. Kuhn, M. W. Anthosen, L. Andera, N. Gellert, et al. 2004. Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor--dependent way. Biochem. Pharmacol. 67: 841-854
DOI
ScienceOn
|
22 |
Lee, D. E., H. Y. Kim, I. H. Song, S. K. Kim, J. H. Seul, and H. S. Kim. 2004. Effect of leptin on the expression of lipopolysaccharide-induced chemokine KC mRNA in the mouse peritoneal macrophages. J. Microbiol. Biotechnol. 14: 722-729
|
23 |
Kim, H. Y., J. R. Kim, and H. S. Kim. 2006. Synergistic effect of interleukin-10 on the expression of lipopolysaccharide-induced IP-10 (CXCL-10) mRNA in mouse peritoneal macrophges. J. Microbiol. Biotechnol. 16: 1605-1612
과학기술학회마을
|
24 |
Wayman, N. S., Y. Hattori, M. C. McDonald, H. Mota-Filipe, S. Cuzzocrea, B. Pisano, P. K. Chatterjee, and C. Thiemermann. 2002. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J. 16: 1027-1040
DOI
ScienceOn
|
25 |
Straus, D. S. and C. K. Glass. 2001. Cyclopentenone prostaglandins: New insight on biological activities and cellular targets. Med. Res. Rev. 3: 185-210
|
26 |
Alleva, D. G., E. B. Johnson, F. M. Lio, S. A. Boehme, P. J. Conlon, and P. D. Crowe. 2002. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-: Counter-regulatory activity by IFN-. J. Leukoc. Biol. 71: 677- 685
|
27 |
Kim, H. Y., H. K. Kim, J. R. Kim, and H. S. Kim. 2005. Upregulation of LPS-induced chemokine KC expression by 15- deoxy--prostaglandin in mouse peritoneal macrophages. Immunol. Cell Biol. 83: 286-293
|
28 |
Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307
|
29 |
Simonin, M. A., K. Bordji, S. Boyault, A. Bianchi, E. Gouze, P. Becume, M. Dauca, P. Netter, and B. Terlain. 2002. PPAR- ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am. J. Physiol. Cell Physiol. 282: 125-133
DOI
|
30 |
Cuzzocrea, S., N. S. Wayman, E. Mazzon, L. Dugo, R. Di Paola, I. Serraino, et al. 2002. The cyclopentenone prostaglandin 15-deoxy--prostaglandin attenuates the development of acute and chronic inflammation. Mol. Pharmacol. 61: 997- 1007
DOI
ScienceOn
|
31 |
Straus, D. S., G. Pascual, M. Li, J. S. Welch, M. Ricote, C. H. Hsiang, L. L. Sengchanthalangsy, G. Ghosh, and C. K. Glass. 2000. 15-Deoxy--prostaglandin inhibits multiple steps in the NF- B signaling pathway. Proc. Natl. Acad. Sci. USA 97: 4844-4849
|
32 |
Azuna, Y., M. Shinohara, P. L. Wang, and K. Ohura. 2001. 15- Deoxy--prostaglandin inhibits IL-10 and IL-12 production by macrophages. Biochem. Biophys. Res. Commun. 283: 344- 346
DOI
ScienceOn
|
33 |
Zhao, M. L., C. F. Brosnan, and S. C. Lee. 2004. 15-Deoxydelta (12,14)- inhibits astrocyte IL-1 signaling: Inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. J. Neuroimmunol. 153: 132-142
DOI
|
34 |
Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR- agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86
DOI
ScienceOn
|